These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5299222)

  • 1. A new treatment for von Willebrand's syndrome.
    Ozsoylu S; Corbacioğlu B
    Turk J Pediatr; 1967 Jan; 9(1):1-7. PubMed ID: 5299222
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new therapy of hemophilia with ranitidine].
    Hu LM; Ye LL; Xu B
    Zhonghua Nei Ke Za Zhi; 1990 Feb; 29(2):85-7, 125. PubMed ID: 2120016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of hepatitis C virus infection in children with haemophilia A and B and von Willebrand's disease.
    Kreuz W; Auerswald G; Brückmann C; Zieger B; Linde R; Funk M; Auberger K; Sutor AH; Rasshofer R; Roggendorf M
    Thromb Haemost; 1992 Jan; 67(1):184. PubMed ID: 1615476
    [No Abstract]   [Full Text] [Related]  

  • 4. Concentrated preparations of Factor 8 (antihaemophilic globulin) in the management of haemophilia A and von Willebrand's disease.
    Castaldi PA; Somer JB; Schiff P; Blackburn CR
    Med J Aust; 1967 Sep; 2(11):481-5. PubMed ID: 5299300
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical staff conference: Hemophilia and von Willebrand's disease. Fourth annual Paul M. Aggeler memorial lecture.
    West J Med; 1974 Mar; 120(3):226-32. PubMed ID: 4544608
    [No Abstract]   [Full Text] [Related]  

  • 6. Acquired haemophilia in association with type III von Willebrand's disease: successful treatment with high purity von Willebrand's factor and recombinant factor VIIa.
    Majumdar G; Phillips JK; Lavallee H; Savidge GF
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1035-7. PubMed ID: 8148477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the clinical management of haemophilia.
    Bloom AL
    Thromb Haemost; 1991 Jul; 66(1):166-77. PubMed ID: 1926047
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemophilia and von Willebrand's disease: genetic considerations.
    Green D
    Ann Clin Lab Sci; 1980; 10(2):123-7. PubMed ID: 6770741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Desamino-8-D-arginine vasopressin nose drops in the treatment of mild hemophilia A and von Willebrand's disease].
    Streit A; Furlan M; Beck EA
    Schweiz Med Wochenschr; 1984 Oct; 114(40):1389-91. PubMed ID: 6333722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the detection of carriers of haemophilia A, B and Von Willebrand's disease.
    Schinco PM; Rizza CR
    Haematologica; 1983; 68(1):124-34. PubMed ID: 6404703
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
    Asatiani E; Kessler CM;
    Haemophilia; 2007 Nov; 13(6):685-96. PubMed ID: 17973844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An inherited hemorrhagic trait with characteristics resembling both mild hemophilia of type A and Von Willebrand's disease.
    Egeberg O
    Scand J Clin Lab Invest; 1965; 17():Suppl 84:25-32. PubMed ID: 5295420
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment of inherited coagulation disorders].
    Blombäck M; Nilsson IM
    Lakartidningen; 1972 Dec; 69():Suppl 4:76-84. PubMed ID: 4540328
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-thrombotic-, non-inhibitor-associated adverse reactions to coagulation factor concentrates for treatment of patients with hemophilia and von Willebrand's disease: a systematic review of prospective studies.
    Franchini M; Makris M; Santagostino E; Coppola A; Mannucci PM
    Haemophilia; 2012 May; 18(3):e164-72. PubMed ID: 22250981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital afibrinogenemia. A case report and therapeutic trials.
    Ozsoylu S; Altay C; Corbacioğlu B
    Turk J Pediatr; 1966 Jan; 8(1):29-35. PubMed ID: 5916625
    [No Abstract]   [Full Text] [Related]  

  • 17. Factor VIII competitive enzyme assay: observations in von Willebrand's variants and hemophiliacs.
    Yorde LD; Yorde DE; Sasse EA; Hussey CV
    Clin Physiol Biochem; 1984; 2(6):298-303. PubMed ID: 6440727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress and problems in hemophilia and von Willebrand's disease.
    Abildgaard CF
    Adv Pediatr; 1984; 31():137-77. PubMed ID: 6440429
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.
    Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lippi G; Manzato F; Bertuzzo D; Gandini G
    Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemophilia and von Willebrand's disease: 1. Diagnosis, comprehensive care and assessment. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(1):19-25. PubMed ID: 7796372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.